MYOMO, INC.

BURLINGTON, Mass. (September 1, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026 at the Lotte Palace […] The post Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference appeared first on Myomo.

Revenue of $11.7 million, increased 21% year over year Four success pillars driving higher revenue growth and operating leverage Raising full year revenue guidance to $45-47 million   Conference call begins at 4:30pm Eastern time today   BURLINGTON, Mass. (August 5, 2026) – Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a wearable medical robotics […] The post Myomo Reports Second Quarter 2026 Financial and Operating Results appeared first on Myomo.

BURLINGTON, Mass. (July 29, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter ended June 30, 2026 on Wednesday, August 5, 2026.  Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide […] The post Myomo to Report Second Quarter 2026 Financial Results on August 5 appeared first on Myomo.

BURLINGTON, Mass. (June 16, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, taking place June 23–24, 2026.  President and […] The post Myomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment Conference appeared first on Myomo.

BURLINGTON, Mass. (May 14, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in two upcoming investor conferences. On May 20, Myomo’s President and Chief Executive Officer Paul Gudonis and Chief […] The post Myomo Announces Participation in Upcoming Investor Conferences appeared first on Myomo.

BURLINGTON, MA. (May 13, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Joseph M. (“Joe”) Manko Jr.  as a director effective May 9, 2026, to serve until the 2027 […] The post Myomo Appoints Joseph M. Manko to its Board of Directors appeared first on Myomo.

Revenue of $10.1 million with 49% of first quarter revenue from recurring patient sources MyoPro® orders received during the quarter were up 12% year-over-year Expanded gross margin, lower operating expenses and narrowed net loss   Conference call begins at 4:30pm Eastern time today   BURLINGTON, Mass. (May 7, 2026) – Myomo, Inc. (NYSE American: MYO) […] The post Myomo Reports First Quarter 2026 Financial and Operating Results appeared first on Myomo.

Burlington, Mass. (May 4, 2026) – Myomo, Inc. (NYSE American: MYO) a wearable medical robotics company and manufacturer of the MyoPro® powered arm brace announces expanded access to the MyoPro device through Ottobock Care clinics nationwide. Ottobock Care will offer the MyoPro through its clinics across the country, helping individuals with upper extremity impairment caused […] The post Myomo Announces Availability of MyoPro at Ottobock Care Clinics in the U.S. appeared first on Myomo.

BURLINGTON, Mass. (May 1, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026.  Management […] The post Myomo to Report First Quarter 2026 Financial Results on May 7 appeared first on Myomo.

BURLINGTON, Mass. — April 20, 2026 — Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of the Myomo® Mobile App, a new digital tool designed to support clinicians and patients throughout the MyoPro® experience. The Myomo Mobile App is […] The post Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement appeared first on Myomo.